上海医药：公司具体利润分配方案视实际经营情况以及对现金的需求而定

Core Viewpoint - Shanghai Pharmaceuticals indicated that the specific profit distribution plan will depend on actual operating conditions and cash needs, emphasizing a commitment to shareholder returns through increased dividend frequency in recent years [1] Group 1 - The company has enhanced its dividend frequency over the past two years to actively reward shareholders [1] - The profit distribution plan for the first half of 2025 has been approved and implemented following the second extraordinary general meeting of shareholders in 2025 [1] - The company will continue to optimize shareholder returns in accordance with its articles of association and actual needs [1]